At Ranedis Pharmaceuticals we are focused on the treatment and management of rare and neglected diseases.
Ranedis Pharmaceuticals is a development stage pharmaceutical company engaged in the development of a novel formulation of an HDAC inhibitor for the treatment of rare genetic, metabolic diseases.